Tore Persson

7.3k total citations · 2 hit papers
70 papers, 5.3k citations indexed

About

Tore Persson is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Tore Persson has authored 70 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 34 papers in Genetics and 33 papers in Surgery. Recurrent topics in Tore Persson's work include Inflammatory Bowel Disease (34 papers), Microscopic Colitis (32 papers) and Helicobacter pylori-related gastroenterology studies (16 papers). Tore Persson is often cited by papers focused on Inflammatory Bowel Disease (34 papers), Microscopic Colitis (32 papers) and Helicobacter pylori-related gastroenterology studies (16 papers). Tore Persson collaborates with scholars based in Sweden, United States and United Kingdom. Tore Persson's co-authors include Robert Löfberg, Olof Selroos, Lars‐Göran Nilsson, Kurt Nikander, T Kava, Tari Haahtela, K. Kiviranta, Markku Järvinen, B Stenius-Aarniala and R Tammivaara and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

Tore Persson

68 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of a β₂-Agonist, Terbutaline, with an Inhaled Corticosteroid, Budesonide, in Newly Detected Asthma

1991 612 citations Tari Haahtela, Markku Järvinen et al. New England Journal of Medicine profile →
Effects of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild Asthma

1994 569 citations Tari Haahtela, Markku Järvinen et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tore Persson Sweden	32	2.9k	2.8k	1.5k	1.4k	1.4k	70	5.3k
Morten Vatn Norway	34	1.8k 0.6×	1.8k 0.6×	1.0k 0.7×	189 0.1×	494 0.4×	76	3.6k
Jens Kjeldsen Denmark	35	1.7k 0.6×	1.3k 0.5×	1.3k 0.8×	212 0.1×	283 0.2×	161	3.6k
Christianne J. Buskens Netherlands	36	1.8k 0.6×	1.1k 0.4×	3.9k 2.5×	281 0.2×	979 0.7×	190	6.0k
J. Enrique Domínguez‐Muñoz Spain	43	896 0.3×	1.5k 0.5×	4.7k 3.1×	301 0.2×	1.1k 0.8×	249	6.3k
Rune Erichsen Denmark	32	1.2k 0.4×	1.1k 0.4×	1.6k 1.1×	158 0.1×	776 0.6×	154	4.3k
Peter F. Whitington United States	57	415 0.1×	2.0k 0.7×	5.0k 3.3×	353 0.2×	1.5k 1.1×	185	8.5k
Joseph L. Melton United States	23	876 0.3×	1.1k 0.4×	2.1k 1.4×	241 0.2×	255 0.2×	28	4.5k
Florian Froehlich Switzerland	34	822 0.3×	978 0.4×	1.9k 1.2×	121 0.1×	1.5k 1.1×	125	4.3k
Neil Hyman United States	50	831 0.3×	923 0.3×	5.4k 3.5×	269 0.2×	2.1k 1.5×	209	8.5k
Albert Cohen Canada	17	1.4k 0.5×	954 0.3×	654 0.4×	195 0.1×	248 0.2×	38	2.9k

Countries citing papers authored by Tore Persson

Since Specialization

Citations

This map shows the geographic impact of Tore Persson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tore Persson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tore Persson more than expected).

Fields of papers citing papers by Tore Persson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tore Persson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tore Persson. The network helps show where Tore Persson may publish in the future.

Co-authorship network of co-authors of Tore Persson

This figure shows the co-authorship network connecting the top 25 collaborators of Tore Persson. A scholar is included among the top collaborators of Tore Persson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tore Persson. Tore Persson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jensen, Dennis M., Stefan Eklund, Tore Persson, et al.. (2017). Reassessment of Rebleeding Risk of Forrest IB (Oozing) Peptic Ulcer Bleeding in a Large International Randomized Trial. The American Journal of Gastroenterology. 112(3). 441–446. 39 indexed citations

Lau, James Y., Tore Lind, Tore Persson, & Stefan Eklund. (2017). Effect of baseline characteristics on response to proton pump inhibitors in patients with peptic ulcer bleeding. Journal of Digestive Diseases. 18(2). 99–106. 2 indexed citations

Eser, Alexander, Jean‐Frédéric Colombel, Paul Rutgeerts, et al.. (2015). Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohnʼs Disease. Inflammatory Bowel Diseases. 21(10). 1–1. 117 indexed citations

Palming, Jenny, Tore Persson, Maria J. Pereira, et al.. (2013). Differences between men and women in the regulation of adipose 11β‐ HSD1 and in its association with adiposity and insulin resistance. Diabetes Obesity and Metabolism. 15(11). 1056–1060. 9 indexed citations

Flook, Nigel, Paul Moayyedi, John Dent, et al.. (2012). Acid-Suppressive Therapy With Esomeprazole for Relief of Unexplained Chest Pain in Primary Care: A Randomized, Double-Blind, Placebo-Controlled Trial. The American Journal of Gastroenterology. 108(1). 56–64. 12 indexed citations

Sjöstrand, Mikaela, Per‐Anders Jansson, Jenny Palming, et al.. (2010). Repeated Measurements of 11β-HSD-1 Activity in Subcutaneous Adipose Tissue from Lean, Abdominally Obese, and Type 2 Diabetes Subjects – No Change Following a Mixed Meal. Hormone and Metabolic Research. 42(11). 798–802. 13 indexed citations

Haahtela, Tari, T Kava, L. Pekka Malmberg, et al.. (2009). Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma. Journal of Allergy and Clinical Immunology. 124(6). 1180–1185. 23 indexed citations

Vakil, Nimish, Nicholas J. Talley, Sander Veldhuyzen van Zanten, et al.. (2009). Cost of Detecting Malignant Lesions by Endoscopy in 2741 Primary Care Dyspeptic Patients Without Alarm Symptoms. Clinical Gastroenterology and Hepatology. 7(7). 756–761. 48 indexed citations

Thia, Kelvin T., William J. Sandborn, James D. Lewis, et al.. (2008). Defining the Optimal Response Criteria for the Crohn's Disease Activity Index for Induction Studies in Patients With Mildly to Moderately Active Crohn's Disease. The American Journal of Gastroenterology. 103(12). 3123–3131. 31 indexed citations

10.

Hanauer, Stephen B., William J. Sandborn, Anders Persson, & Tore Persson. (2005). Budesonide as maintenance treatment in Crohn's disease: a placebo‐controlled trial. Alimentary Pharmacology & Therapeutics. 21(4). 363–371. 61 indexed citations

11.

Pietinalho, Anne, P Tukiainen, Tari Haahtela, Tore Persson, & Olof Selroos. (2002). Early Treatment of Stage II Sarcoidosis Improves 5-Year Pulmonary Function. CHEST Journal. 121(1). 24–31. 104 indexed citations

12.

Geboes, Karel, et al.. (2001). Grading system for inflammation in ulcerative colitis. Reply. Gut. 48(5). 737–737.

13.

Hellers, G, Antoine Cortot, Derek P. Jewell, et al.. (1999). Oral budesonide for prevention of postsurgical recurrence in Crohn's disease. Gastroenterology. 116(2). 294–300. 201 indexed citations

14.

Thomsen, Ole Østergaard, Antoine Cortot, D P Jewell, et al.. (1998). A Comparison of Budesonide and Mesalamine for Active Crohn's Disease. New England Journal of Medicine. 339(6). 370–374. 228 indexed citations

15.

Campieri, Massimo, et al.. (1997). Oral budesonide is as effective as oral prednisolone in active Crohn’s disease. Gut. 41(2). 209–214. 259 indexed citations

16.

Löfberg, Robert, Paul Rutgeerts, H Malchow, et al.. (1996). Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.. Gut. 39(1). 82–86. 157 indexed citations

17.

Löfberg, Robert, Åke Danielsson, Ole B. Suhr, et al.. (1996). Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis. Gastroenterology. 110(6). 1713–1718. 136 indexed citations

18.

Greenberg, Gordon R., Brian G. Feagan, François Martin, et al.. (1994). Oral Budesonide for Active Crohn's Disease. New England Journal of Medicine. 331(13). 836–841. 413 indexed citations

19.

Haahtela, Tari, Markku Järvinen, T Kava, et al.. (1991). Comparison of a β₂-Agonist, Terbutaline, with an Inhaled Corticosteroid, Budesonide, in Newly Detected Asthma. New England Journal of Medicine. 325(6). 388–392. 612 indexed citations breakdown →

20.

Danielsson, Åke, G Hellers, E Lyrenäs, et al.. (1987). A Controlled Randomized Trial of Budesonide versus Prednisolone Retention Enemas in Active Distal Ulcerative Colitis. Scandinavian Journal of Gastroenterology. 22(8). 987–992. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact